Expert Details
Bioscience, Pharma, Biotechnology, Research, Publications, Funding
ID: 731004
Canada
Diabetes Association, the Province of Ontario, Canadian Institutes of Health Research and Heart & Stroke Foundation of Ontario. His peer-reviewed research funds have come from Canadian Institutes of Health Research, Canadian
Diabetes Association and Heart & Stroke Foundation of Canada, Korean Ministry of Education Science & Technology and AstraZeneca. Studies have resulted in publications in leading journals including Diabetes, Nature Reviews
Cardiology, Proc Natl Acad Sci USA, Journal of Clinical Endocrinology & Metabolism, Journal of Biological Chemistry, Endocrinology and Cell Metabolism. He has also served as Chief Scientific Officer and Diabetes Group Leader at
Institut Pasteur Korea, a world-leading translational research institute.
“Employer demonstrated the high level of integrity, honesty, and professionalism in consulting services that were focused in the world of life sciences and diagnostics. The services were exceptionally helpful for the directions of our sales strategies and management of pipeline which we would not have been able to accomplish on our own. “
President
SI Healthcare Ltd.
“We have opened up new product areas and revenue streams based on astute advice from Employer. Our interactions with TBCG were gratifying and I strongly recommend their services. “
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 1994 | Degree: PhD | Subject: Molecular Pharmacology | Institution: University of Glasgow |
| Year: 1990 | Degree: BSc | Subject: Pharmacology | Institution: University of Glasgow |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 2012 to Present | Employer: Undisclosed | Title: President | Department: |
Responsibilities:Owner and operator. |
|||
| Years | Employer | Title | Department |
| Years: 2001 to Present | Employer: Undisclosed | Title: Professor | Department: |
Responsibilities:Research, administration, teaching. |
|||
Government Experience
| Years | Agency | Role | Description |
|---|---|---|---|
| Years: 2003 to 2008 | Agency: Canadian Institutes of Health research | Role: Committee member and reviewer | Description: Peer-review of operating grant applications. |
| Years: 2005 to 2005 | Agency: FRSQ (Fonds de la recherche en santé du Québec) | Role: | Description: Chair of on-site review committee (Diabetes institute initiative) |
International Experience
| Years | Country / Region | Summary |
|---|---|---|
| Years: 2008 to 2012 | Country / Region: Korea | Summary: Chief Scientific Officer and Diabetes Group Leader - Institut Pasteur Korea. |
Career Accomplishments
| Associations / Societies |
|---|
| Canadian Diabetes Association |
| Professional Appointments |
|---|
| Diabetes Frontiers in Cellular Endocrinology
American Journal of Physiology: Endocrinology and Metabolism Fonds de la recherche en Santé du Québec (FRSQ) on-site review committee CIHR operating grants (Metabolism) review panel Heart & Stroke Foundation of Canada grant review committee Canadian Diabetes Association grant review committee Canadian Diabetes Association personnel awards review committee |
| Awards / Recognition |
|---|
| Canadian Diabetes Association Scholar Premiers Research Excellence Award Canadian Institutes of Health Research New Investigator Heart & Stroke Foundation Career Investigator |
| Publications and Patents Summary |
|---|
| He has consistent reputation of publishing in top high impact journals every year. |
Additional Experience
| Training / Seminars |
|---|
| Seminars by Expert include: Society for Heart & Vascular Metabolism Annual Meeting, Oxford, UK International Symposium on Adiponectin Biology and Medicine, Hokkaido, Japan Montreal Heart Institute, Canada Korean Association for Study of Obesity Annual Conference, Seoul, Korea. Singapore Bioimaging Consortium, Dept Metabolic Medicine, Singapore 6th Annual Changsha Diabetes and Immunology Symposia, Hunan, China American College of Cardiology Conference, Atlanta, USA European Association for the Study of Diabetes Conference, Stockholm, Sweden |
| Vendor Selection |
|---|
| Partnerships with Diamed Lab Supplies, Genolution, Antibody & Immunoassay Services (AIS) and SI Healthcare Ltd. |
| Marketing Experience |
|---|
| Pharmaceutical R&D (especial knowledge of South Korea). |
| Other Relevant Experience |
|---|
| • Editing and assessment of manuscripts & research grant applications • Introduction to expert networks for collaboration • R&D project evaluation and advising spanning assay design & development, preclinical testing and clinical trials • Advising on current health research trends and future strategies • Evaluation of project proposals on new healthcare or R&D initiatives |
Language Skills
| Language | Proficiency |
|---|---|
| French & Korean | French - reading is satisfactort but conversation difficult. Korean - basic everyday usage. |
Fields of Expertise
cardiovascular disease, cardiovascular drug therapy, diabetes treatment, drug development, drug discovery, pharmaceutical research, pharmaceutical research and development, type 2 diabetes, diabetic ketoacidosis, diabetic coma, diabetic neuropathy, diabetic complication, diabetic angiopathy, diabetic nephropathy, applied biochemistry, omega-3 fatty acid, C peptide, hyperglycemia, hypoglycemia, applied biotechnology, inflammation, metabolic engineering, carbohydrate metabolism, pharmaceutical industry, medical technology, pharmaceutical drug, recombinant DNA technology, drug, monoclonal antibody, metabolism, insulin, hormone, genetic engineering, endocrinology, endocrine disease, diabetic retinopathy, diabetes, biotechnology, biology, biological modeling, biochemistry, anti-inflammatory drug